“If this problem was left undetected – by age seven [my daughter] would undoubtedly have lost virtually all vision in the eye…I hope other parents realize how fortunate they are to have “cutting edge” technology available for their children’s health.”  

D.T., Jackson, TN

INSIDE
iSCREEN

Our Management Team

Science and Strategy – Clearly in Focus.

Easy and affordable, iScreen Vision can screen for amblyopia risk factors and other serious eye abnormalities…

iScreen Vision technology was created by a pediatric ophthalmologist and an engineer from the U.S. Army Aviation and Missile Command, with input from pediatricians across the country. Their collaborative work resulted in a ground-breaking digital device. Easy and affordable, iScreen Vision can screen for risk factors for amblyopia (commonly called “lazy eye”) and other serious eye abnormalities in children as young as one-year old. Studies show earlier diagnosis of vision problems can lead to more effective treatment and better patient outcomes.14

iScreen Vision Management Team

BBBuck Brown – Chief Executive Officer
Buck Brown joined iScreen Vision as its CEO and President in May 2010, bringing over 18 years of executive management experience in marketing, sales, and human resources at NYSE high-growth companies.

Prior to iScreen Vision Mr. Brown was the Senior Vice President of Marketing & Sales for Storage USA (owned by GE Capital) and subsequently for Extra Space Storage, a Salt Lake City based company. In addition, Mr. Brown served as Vice President of Human Resources and Communications for AutoZone during the company’s high-growth phase going from 500 to more than 2,000 stores. Prior to AutoZone, he was a reporter for The Wall Street Journal in its Dallas and New York City news bureaus.

Mr. Brown graduated cum laude from Princeton University with a degree from Princeton’s Woodrow Wilson School of Public and International Affairs and earned his MBA from Harvard Business School.

DJDarryl Jackson – Chief Operating Officer
Darryl Jackson is a seasoned business executive with a wealth of management experience in sales, strategic planning, and engineering. Mr. Jackson has been extremely successful in leading startup businesses within several Fortune 100 companies including General Electric, Xerox, and Kodak. At Kodak, Mr. Jackson turned a digital photo printer startup pilot into more than a $100 million business unit in 18 months.

Prior to joining the Company, Mr. Jackson served as President and CEO of Digital Q and Centiba. Both were startup digital coupon technology companies based in Memphis, Tennessee.

Mr. Jackson is a graduate of Tuskegee University with a degree in Mechanical Engineering. Mr. Jackson earned his MBA from the University of Rochester.

 

iScreen Vision Board of Directors

Ross A. Kennedy, M.D., Director
Dr. Kennedy brings a wealth of ophthalmologic knowledge as well as numerous medical accolades to the Company’s management team. Dr. Kennedy’s primary area of research is digital ocular photoscreening, and he is a co-inventor of the Company’s imaging device.

Dr. Kennedy has been awarded numerous fellowships in pediatric ophthalmology including: Johns Hopkins University, The Children’s Hospital National Medical Center in Washington D.C., and Smith-Kettlewell Institute of Visual Sciences in San Francisco. He is a member of the American Association for Pediatric Ophthalmology and Strabismus and is a Fellow of the American Academy of Pediatrics.

Dr. Kennedy attended medical school at McGill University in Montreal, Quebec and received an M.D.C.M. degree in 1978.

John W. Stokes, Jr., Director
Mr. Stokes is a private investor. Mr. Stokes previously was with Morgan Keegan & Company, and its successor companies, Regions Financial Corp. and Raymond James Financial Inc., from 1970 until 2015. He was formerly Morgan Keegan’s Vice Chairman and Managing Director.

Mr. Stokes’ previous investment experience includes working at Merrill, Lynch, Pierce, Fenner & Smith for ten years. Previously, Mr. Stokes served on the board of directors of O’Charley’s Inc., RFS Hotel Investors, Inc., Educare Child Care Services, Inc. and AccuCount Services, Inc.

Mr. Stokes received his Bachelor’s Degree from Vanderbilt University in 1959.

Jan Bouten, Director
Mr. Bouten is a partner with Innova and has strong operating experience in the high-tech industry as well as the venture capital industry.

Mr. Bouten joined the Company’s board of directors in conjunction with the closing of Innova’s investment in the Series A preferred shares. Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the biosciences, technology and agbio fields. Prior to joining Innova, Mr. Bouten was a partner at a $235 million venture capital firm in Research Triangle Park, North Carolina focusing on early-stage healthcare and information technology companies

Mr. Bouten holds a B.S. degree in Software Engineering from Fontys University in the Netherlands, a M.Sc. degree in Human-Computer Systems focusing on Artificial Intelligence from DeMontfort University in the UK, and an MBA from Duke University’s Fuqua School of Business.

Gary Stevenson, Director
Mr. Stevenson co-founded MB Venture Partners in 2001 after six years in health care investment banking and equity research. He also spent seven years in a variety of general management roles with Abbott Laboratories, one of the largest and most diversified health care companies in the world.

Mr. Stevenson holds an undergraduate degree in accounting from the University of Missouri. He also earned an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University. He is a Certified Public Accountant and a Chartered Financial Analyst.

Mr. Stevenson is a board member or observer for several MBVP portfolio companies, including AxioMed Spine, BioSET, Kereos, KFx Medical, Hapten Sciences, iScreen Vision, Restore Medical, S2 Interactive, Spinal Restoration, and Visioneering.

iScreen Vision Founder

Jack R. Bellows, Co-Inventor & Co-Founder
Jack Bellows became aware of the need for improvements in vision diagnosis after a personal family experience; an experience that became the genesis for his idea in 1996. At that time Mr. Bellows developed and patented the Company’s imaging device in collaboration with a U.S. Army Missile Command engineer, and Ross A. Kennedy, M.D., a pediatric ophthalmologist and authority on digital photo screening.

Prior to founding the Company, Mr. Bellows blended careers of food processing and investment banking for 35 years. As of 2012, Mr. Bellows has retired from the Company.

Mr. Bellows studied business administration at the University of Alabama.

14. Kirk V.G., Clausen M.M., Armitage M.D., Arnold R.W. − Preverbal photoscreening for amblyogenic factors and outcomes in amblyopia treatment: early objective screening and visual acuities. Arch Ophthalmol. 2008; 126(4): 489-92.